U.S. Physical Therapy (NYSE:USPH) Announces Earnings Results

U.S. Physical Therapy (NYSE:USPH) issued its earnings results on Wednesday. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.76 by $0.04, Zacks reports. The business had revenue of $222.56 million during the quarter, compared to analyst estimates of $214.48 million. U.S. Physical Therapy had a return on equity of 10.00% and a net margin of 3.60%. U.S. Physical Therapy’s revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.66 EPS.

U.S. Physical Therapy Stock Performance

Shares of USPH stock traded up $2.75 during trading hours on Friday, reaching $99.95. 149,424 shares of the company traded hands, compared to its average volume of 205,062. The firm has a 50-day moving average price of $83.78 and a 200 day moving average price of $76.97. The company has a market cap of $1.49 billion, a P/E ratio of -74.06, a P/E/G ratio of 2.27 and a beta of 1.16. U.S. Physical Therapy has a 12-month low of $58.19 and a 12-month high of $101.18. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.27 and a quick ratio of 1.27.

U.S. Physical Therapy Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 11th. Stockholders of record on Monday, November 16th will be paid a $0.46 dividend. The ex-dividend date of this dividend is Monday, November 16th. This represents a $1.84 annualized dividend and a dividend yield of 1.8%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 1,082.35%.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on USPH. Weiss Ratings reiterated a “hold (c-)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 26th. Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 19th. JPMorgan Chase & Co. raised their target price on shares of U.S. Physical Therapy from $90.00 to $95.00 and gave the stock an “overweight” rating in a report on Friday, September 11th. Finally, Barrington Research lifted their target price on shares of U.S. Physical Therapy from $90.00 to $98.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $98.25.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) operates outpatient physical therapy clinics throughout the United States. The company provides treatment and rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength and physical function.

In addition to company-operated clinics, U.S. Physical Therapy develops and manages physical therapy practices in partnership with local physical therapists. Its services generally include orthopedic and sports rehabilitation, post-operative therapy, treatment for musculoskeletal conditions and other forms of outpatient rehabilitation.